Technical Analysis for NXS - Next Science Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Crossed Above 20 DMA | Bullish | -10.00% | |
| Inside Day | Range Contraction | -10.00% | |
| Wide Bands | Range Expansion | -10.00% | |
| Gapped Up | Strength | -10.00% | |
| 20 DMA Resistance | Bearish | -3.57% | |
| Wide Bands | Range Expansion | -3.57% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 10 hours ago |
| 10 DMA Support | about 10 hours ago |
| Fell Below Previous Day's Low | about 13 hours ago |
| 10x Volume Pace | about 13 hours ago |
| 5x Volume Pace | about 13 hours ago |
Get a Trading Assistant
Next Science Limited Description
Next Science Limited is an Australia-based medical technology company. The Company focuses on the development and commercialization of its Xbio technology to reduce the impact of biofilm-based infections in human health. Its products include Bactisure Surgical Lavage, BlastX Antimicrobial Wound Gel, TorrentX Wound Wash, SurgX Sterile Antimicrobial Wound Gel for Surgical Site Infections and Acne Treatment. The SurgX is a surgical gel designed to help reduce superficial surgical site infections (SSIs) and protect wound tissue to facilitate natural healing. Its Bactisure is designed to remove structurally resistant forms of bacteria (biofilm) through physical deconstruction of the extracellular polymeric substance (EPS) matrix, making bacteria more susceptible to traditional antibiotics and the body’s normal defense mechanisms. BlastX is an antimicrobial wound gel and deconstructs the bacterial biofilm, the gel envelops and eliminates the bacteria.
Classification
Sector: Basic Materials
Industry: Independent Oil & Gas
Keywords: Health Construction Biology Medical Technology Sms Film Infection Bacteria Wound Bacteriology Microbiology Antibiotic Antibiotics Antimicrobial Healing Infections Acne Bio Technology Environmental Microbiology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.47 |
| 52 Week Low | 0.115 |
| Average Volume | 217,354 |
| 200-Day Moving Average | 0.268 |
| 50-Day Moving Average | 0.176 |
| 20-Day Moving Average | 0.145 |
| 10-Day Moving Average | 0.148 |
| Average True Range | 0.015 |
| RSI (14) | 39.39 |
| ADX | 17.78 |
| +DI | 17.219 |
| -DI | 28.138 |
| Chandelier Exit (Long, 3 ATRs) | 0.169 |
| Chandelier Exit (Short, 3 ATRs) | 0.161 |
| Upper Bollinger Bands | 0.175 |
| Lower Bollinger Band | 0.115 |
| Percent B (%b) | 0.33 |
| BandWidth | 40.966 |
| MACD Line | -0.010 |
| MACD Signal Line | -0.012 |
| MACD Histogram | 0.0013 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.165 | ||||
| Resistance 3 (R3) | 0.168 | 0.162 | 0.160 | ||
| Resistance 2 (R2) | 0.162 | 0.154 | 0.160 | 0.158 | |
| Resistance 1 (R1) | 0.148 | 0.149 | 0.145 | 0.145 | 0.157 |
| Pivot Point | 0.142 | 0.142 | 0.140 | 0.140 | 0.142 |
| Support 1 (S1) | 0.128 | 0.134 | 0.125 | 0.125 | 0.113 |
| Support 2 (S2) | 0.122 | 0.129 | 0.120 | 0.112 | |
| Support 3 (S3) | 0.108 | 0.122 | 0.110 | ||
| Support 4 (S4) | 0.105 |
